10

11

12

13

14

3 Bt

16

17

18

19

20

21

22

23

24

25

185

The role of the Advisory Board is three-fold,
and this is also spelled out. One is that the
Board is specified as being responsible for
commenting and assessing what is being done,
specifically by the NIOSH group, in Lerms of the
rule-making that has occurred dealing with how one
goes about determining probability of causation.
The exact words from the legislation are specified
here on the slide, but basically that is a role
that the Board is required tn carry out.

The Board is also required to advi-- and this
advice goes to the Secretary of Health and Human
Services -- to advise the Secretary on the
validity and quality of the dose reconstruction
efforts. And that’s an ongoing process. In fact,
the Board is in the process of -- of using a
contractor to help it in -- help "it", the Board -
- dn carrying out Lhis responsibility in
evaluating the dose reconstructions that are being
done by NIOSH and its contractor.

And then finally, at the request of the
Secretary, the Board is to advise the Secretary on
whether or not there is a class of DOE employees
for whom it is not feasible to estimate dose and

whether or not there’s a likelihood that such

NANCY LEE & ASSOCIATES



tw

y Ey J
18
a9;

20

24

25

176

DR. NETON: (Off microphone) Well, I was
hoping one of our people were taking these down,
but (Inaudible) - I'll get the numbers and I’11
(Inaudible). I‘11 put them on a slide.

MR. ELLIOTT: Paducah, 732, ten completed.
Pantex, 279 -- or excuse me, zZ¥/, eight completed.
Portsmouth Gaseous Diffusion Plant -- is that
next? Yeah. Okay, that’s 314 and 12 completed.
Rocky Flats, 807 and 26 completed. Savannah River
Site, 1,965 claims, 515 complered. Qak Ridge
National Laboratory, X-10, 997 claims, 2-- I think
it's 25 completed. And Y-12, 1,989 claims, 120
completed.

You want to go into AWEs?

DR. ZIEMER: Can you give us the ones on that
next slide, Bethlehem, Blockson, so on?

DR. NETON: You want that next slide for
AWEs?

DR. ZIEMER: Yes.

MR. ELLIOTT: Bethlehem Steel, 494 claims,
448 completed. Blockson Chemical, 10/7 claims, 4y
completed. Huntington Pilot Plant, 63 claims, 23
completed. Mallinckrodt Chemical Company and
this is on Destrehan Street -- 163 claims, 24

completed, so that does not include the other

NANCY LEE & ASSOCIATES



10
11
12
13
14
15
16
ph

18

20
21
22
23
24

25

18)

or apportion the time accordingly.

But let me begin then and take just a few
minutes to talk a little bit about the role of
this Advisory Board. I already indicated this is
our 21st meeting. This Board has been meeting
regulariy for the past two years, actually, which
Means that we meet nearly every month. And one of
the questions is what do we do. And I want to
familiarize you with that so that when you make
your public comment, what you say might be helpful
to us in carrying out our role and our function.
dim, if you'll advance the slide there.

First of all, to remind you that the program
of which we are a part involves a number of
groups. There are a number of Federal agencies
involved with this, and I'm not going to discuss
their roles -- Department of Labor, Health and
Human Services -- particularly NIOSH or Naliunal
Institutes for Occupational Safety and Health,
Secretary of Energy or Department of Energy, and
the Attorney General. Those individuals and their
agencies all have various roles that are defined
by the legislation that brought this program into
existence.

In addition to those Federal agencies then,

NANCY LEE & ASSOCIATES



10

re

12

14

15

16

17

18

a:

20

21

22

23

24

25

178

contractor to review something that’s half done.
I mean and -- or where there’s large, important
things that are going to affect a lot of claims
completed. Now if it's something that affects a
small number or whatever, it’s not an important
issue, then i think that’s different.

DR. NETON: (Off microphone) My gut feeling,
there are very few that have large, gaping holes.

An exception may be residual contamination in AWEs

we haven’t figured out yet (Inaudible). I hope I
can fit it all in one slide. I mean this is
already kind of crowded and (Inaudible). I might

try to break it into two.

DR. ZIEMER: Okay. We will return to this
topic then tomorrow as part of our work session.
Now we're going to adjourn here momentarily. I do
want to ask Jim if you would provide a straw man
wording on your proposed motion for tomorrow
concerning a letter to the Secretary, and that‘il
give us an opportunity then to do some
wordsmithing, if necessary. Okay?

Any other comments before we recess? We’re
going to recess until 7:00 p.m., at which time
we'll reconvene for the public comment session of

our meeting.

NANCY LEE & ASSOCIATES



10
11
12
13
14
15
16

17

13
20
21
22
23

24

177

Mallinckrodt sites. That’s only Destrehan Street.
While we're there, though, Weldon Spring plant,
129 claims, seven completed. Aliquippa Forge, 21
claims, three completed.

I can’t report on -- my report is not
generated so that I can easily provide you numbers
on complex-wide uranium facilities. That’s a
large number of different sites. Nor can you -- I
don’t think I've got anything here for Tennessee
Valley Authority. I don't believe we've dnnrm any.

DR. ZIEMER: Jim, when you provide your slide
tomorrow, will that then indicate the status of
the -- the reviews on the

DR. NETON: I can break it down into whether
-- whether the green means that it’s actually
approved and available for review now or --

DR. ZIEMER: Yeah, that’s what I’m asking.

DR. NETON: (Off microphone) -- under --
under (Inaudible).

DR. MELIUS: Some idea whether it’s
comprehensive or complete. There aren't large
sections that are reserved that would -- that
you're working on that

DR. NETON: Right, I think --

DR. MELIUS: I don't think we want our

NANCY LEE & ASSOCIATES



10
11
12
13

14

16
17
18
i9
20
21
22

24

25

180

There's a book at the back table. Most of you I
think have already registered. If you neglected
to do that or missed it, please do so so we have a
record of your attendance with us here tonight.

My name is Paul Ziemer and I serve as
Chairman of the Advisory Board on Radiation and
Worker Health. I would like to spend a few
minutes here at the beginning, particularly for
the benefit of a number of visitors who we have --
and we do welcome, particularly thase from the
Savannah River Site that are with us here this
evening, I/’d like to take just a few minutes and
familiarize you with the role of the Advisory
Board with respect to the larger program, the
Energy Employees Occupational Illness Compensation
Program, And then we will have an opportunity for
-- primarily for public comment, hearing from you.

we do actually ask that if you wish te make
public comment, you also sign up to do so. Some
of you have already done that. If you do want to
make public comment and have not already signed up
to do so, Cori in the back has the sign-up sheet
for public comment. The reason we ask you to sign
up is simply so we have an idea of how many wish

to comment and whether or not we need to restrict

NANCY LEE & ASSOCIATES



N

w

=

wn

a

_

oe

‘

10

11

12

13

14

uw

17

i8

19

24

25

172

DR. MELIUS: (Off microphone) (Inaudible)

MR. ELLIOTT: Well, we have 443 claims for
Fernald; we've finished 51.

UNIDENTIFIED: (Off microphone) (Inaudible)

MR. ELLIOTT: {Off microphone) I'd have to go
through these. They’re not in (Inaudible).

DR. DEHART: If we're going to do that, let
Jim put the slide up and then we can figure out
where it goes on this chart.

DR. ZIEMER: Yeah, Jim, can you (Inaudible)
that slide?

MR. ESPINOSA: Or could we have somebody type
46 2: ors. 5

Paul, can we gel somebody to type that in up
on the screen?

UNIDENTIFIED: (Off microphone) Can you put
your slide --

DR. ZIEMER: Yeah, can you pull that slide
up, Jim, slide number --

DR. NETON: (Off microphone) (Inaudible)

DR. ZIEMER: -- slide numher five, or net?

DR. NETON: What I would propose is a slight
modification of the slide where I could -- if you
recall, I had green dots for just whether it was

finalized or in OCAS review. I would suggest that

NANCY LEE & ASSOCIATES



10

ni i

12

1 =}

14

iS

16

17

19

20

21

22

23

24

2s

183

-- indeed, we have quite a cross-section of
people.

I’ve introduced myself as Chair, Paul Ziemer.
Our Federal official, who serves as our --
essentially our Executive on this committee -- is
the Director of the Office of Compensation
Analysis and Support for NIOSH and that's Larry
Elliott. Larry, make a motion here -- no
applause, please.

MR. ELLIOTT: (Indicating)

DR. ZIEMER: Then absent this evening, and
he'll be joining us tomorrow, we believe, is Dr.
Henry Anderson, who's a medical officer from the
State of Wisconsin.

Antonio, or Tony, Andrade from Los Alamos
over here.

DR. ANDRADE: (Indicating)

DR. ZIEMER: Ruy DeHart, Dr. Dellart ia from
the State of Tennessee, so glad te have Roy on the
committee,

DR. DEHART: (Indicating)

DR. ZIEMER: And then Richard Espinosa.

MR. ESPINOSA: (Indicating)

DR. ZIEMER: Richard is from the Los Alamos

National Laboratory. And then continuing, Michael

NANCY LEE & ASSOCIATES



11
12
13
14
£3,
16
17
18
5 A
20
21
22
23
24

25

162

this Advisory Board exists. This Board was
appointed by the President under authority that is
spelled out in the legislation. Could we have the
next slide?

The Advisory Board is specified as consisting
of no more than 20 members appointed by the
President, who also designates the Chair of the
committee. Now in reality, the committee does not
have 20 members, The White House has appointed
just a dozen of us, plus there is a Federal
official, and I’m going to introduce those folks
in just a moment.

The Executive Memorandum that spelis out the
operation of this Advisory Board also specifies
that the membership should include affected
workers and their representatives, and
representatives of the science and -- or
scientific and medical communities, as well.

So with that as a little bit of background,
let me introduce the members of the Board. I’m
going to put their names here on the screen -

dim, if you'll give us the next slide -- and I
will identify to you the various members of tho
Board. The slide also contains a phrase or two

giving you a little idea of what their background

NANCY LEE & ASSOCIATES



12
13

14

16
a bed
18
19
20
21
22
23

24

179

DR. MELIUS: Just one more thing just to
reiterate for tomorrow morning if Martha or
somebody could provide for us what any other
scheduled tasks should -- scheduled products or
deliverables, should tasks one and three get
awarded in the near future so that we can figure
that --

DR. ZIEMER: Or at least if there’s some
items that we need to take action on right away,
then --

DR. MELIUS: (Off microphone) (Inaudible).

DR. ZIEMER: Right, thank you. Then we‘ll
recess until 7:00 o’clock this evening. Thank
you.

(Inaudible) this room and you should be able
to leave things here if you need to.

(Whereupon, a recess was taken to 7:00 p.m.)

INTRODUCTION
(7:00 p.m.)

DR. ZIEMER: Good evening, everyone. This
session this evening is the public comment period
portion of the 2ist meeting of the Advisory Board
on Radiation and Worker Health. I‘d like to
remind you, if you haven’t already done so, to

please register your attendance with us tonight.

NANCY LEE & ASSOCIATES



13

14

15

16

17

1S

20

22

23

24

25

175

1,631 claims, 64 completed. INEEL, 566 claims, 26
completed. The IOP is Iowa Ordnance Plant, 554
claims, zero completed. Mound, 273 claims in
house and --

DR. ZIEMER: Whoa, whoa, whoa, you skipped --

MR. ELLIOTT: On, LANL, I'm sorry --

DR. ZIEMER: K-25.

MR, ELLIOTT: Okay, well, let me give you
Mound -- I'm on Ohio, so let me give you Mound,
273 in house and 18 completed.

Let me go back to Tennessee and get K-25. K-
25, 972 and 30 completed.

Los Alamos, 551, nine completed. Mound, 273,
18 completed. Nevada Test Site, 868 claims, 21
completed. And you can make any comment about
this while I'm searching. I mean there’s several
comments you might want to make about some of

these -- like you did on the first one, you know -

DR. NETON: I need to -- I need to fill out
these circles tonight with some little finer
detail. tf can do that.

DR. MELIUS: (OC£ microphone) Miuht you also
put some of these numbers into a slide and give us

(Inaudible) ?

NANCY LEE & ASSOCIATES



10

11

12

13

14

16

LS,

18

Le

20

21

22

234

24

25

186

individuals may have health endangerment due to
their exposures to radiation. That then is

related to what's called the Special Exposure

Cohort.

The Board does not -- does not -- cassy out
the dose reconstructions individually. We do not
process the cases, the claims that are made. We

do not in fact deal with individual claims, but
rather the evaluation and the review and the
examination of the procesa hy which these things
are going on.

So in terms of the public comment, I need to
tell you that we are not here at this meeting and
our other meetings specifically in the role of a
question/answer type of session. We do like to
get public comment so that we understand what
things look like out there. And even though we --
we do not deal and cannot in the public forum deal
with people's individual cases, we're glad to --
if you want to share something about a case you
may be involved in, we’re glad to hear that
insofar as it helps us understand how things are
going, how people are -- how cases are being
handled; are there things in the system that need

to be looked at.

NANCY LEE & ASSOCIATES



12

13

14

15

17

18

19

20

21

22

23

24

25

174

DR. MELIUS: Yeah, I just get a little
concerned that -- this sort of mix of closed
session and open issues, and I agree with you,
it’s -- till we -- made some decisions, we don’t
know, but at least we ought to be thinking about
it so we can talk that if this is what needs to be
done and -- and what's the contingency schedule
‘cause presumably if it's something -- a task is
awarded, then there’1ll be some time for NIOSH to
proceee it, so what will that time frame be.

Maybe it's something -- the second conference call
becomes something we have to do something at.

DR. ZIEMER: Okay, here’s the chart. Fernald
is the first one, 443 claims.

MR. ELLIOTT:

house and 51 completed. And
when I say completed, these are the -- over to DOL
for decisions.

DR. NETON: I'd just like to point out that
there is no site profile completed for Fernald at
this time. Those are in house -- many of those
chapters are in house for review, but those must
have been completed under the DOE complex-wide
technical bulletin I talked about this morning,
just so the Board's aware of that.

MR. ELLIOTT: Hanford -- Hanford would be

NANCY LEE & ASSOCIATES



w

o

18

19

20

173

I would make it a little more detailed and put in
the ones that have actually been approved that are
out on our web site.

MR. PRESLEY: Yes.

DR. NETON: That's not a problem.

MR. PRESLEY: Larry, are you going to take
these in the order they are?

MR. ELLIOTT: I was planning to.

DR. MELIUS: The thing I think we need to
talk about is for tasks one and three, which we'll
deal with in closed session. But someone needs to
take a look at the task order for those and the
schedule for that ‘cause depending on our
decisions tomorrow there may be deliverables for
those that come due within that next two-month
time period and -- and, you know -- and for the

work that’s contingent on that, and I think we

need to figure out how that’s -- might -- how that
might fit into the schedule and if this -- may be
as simple as just defer -- deferring that to the

conference call, aiso, but that may be a litrle
bit -- again, the schedule --

DR. ZIBMER: I don’t think we'll know till we
talk tomorrow, though, because recall that last

time we changed some deliverable dates.

NANCY LEE & ASSOCIATES



18

a3:

20

21

22

23

24

25

184

Gibson, with Babcock and Wilcox* in Ohio.

MR. GIBSON: (Indicating)

DR. ZIEMER: Mark Griffon is an entrepreneur,
has his own consulting firm.

MR. GRIFFON: (Indicating)

DR. ZIEMER: Dr. James Melius, who is from
New York and involved with the New York State
Labor's Health and Safety Trust Fund.

DR. MELIUS: (Indicating)

DR. ZIEMER: Wanda Munn, a retired nuclear
engineer from the Richland, Washington area near
the Hanford site.

MS. MUNN: (Indicating)

DR. ZIEMER: Charles Owens, who's with U.S.
Enrichment Corporation in Paducah.

MR. OWENS: (Indicating)

DR. ZIEMER: Robert Presley, retired

mm
"
°
|
rt
ty
o

Oak Ridge facilities, an engineer.

MR. PRESLEY: (Indicating)

DR. ZIEMER: And then Dr. Gen Roessler, a
retired professor, previously of Florida and now
living in the warm state of Minnesota.

DR. ROESSLER: (Indicating)

DR. ZIEMER: So that is the advisory

committee, Could we have the last slide?

NANCY LEE & ASSOCIATES